Collectively, MST1 deficiency drives SREBP2-mediated cholesterol synthesis, FC overload, and NLRP3 inflammasome activation, synergizing with dietary stress to amplify NASH severity. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.